CO2017005500A2 - Método para la producción de un sistema de administración farmacéutica - Google Patents
Método para la producción de un sistema de administración farmacéuticaInfo
- Publication number
- CO2017005500A2 CO2017005500A2 CONC2017/0005500A CO2017005500A CO2017005500A2 CO 2017005500 A2 CO2017005500 A2 CO 2017005500A2 CO 2017005500 A CO2017005500 A CO 2017005500A CO 2017005500 A2 CO2017005500 A2 CO 2017005500A2
- Authority
- CO
- Colombia
- Prior art keywords
- delivery system
- production
- pharmaceutical delivery
- pharmaceutical
- improve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
La presente invención se refiere a un método para la producción de un sistema de administración farmacéutica, al uso de un carbonato de calcio reaccionado en superficie para mejorar la friabilidad de un sistema de administración farmacéutica al igual que para mejorar la capacidad de flujo de un sistema de administración farmacéutica, y a un sistema de administración farmacéutica obtenido por el método.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14199037.4A EP3034070A1 (en) | 2014-12-18 | 2014-12-18 | Method for the production of a pharmaceutical delivery system |
US201462095865P | 2014-12-23 | 2014-12-23 | |
US201562232516P | 2015-09-25 | 2015-09-25 | |
PCT/EP2015/080016 WO2016096997A1 (en) | 2014-12-18 | 2015-12-16 | Method for the production of a pharmaceutical delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2017005500A2 true CO2017005500A2 (es) | 2017-09-29 |
Family
ID=52338877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2017/0005500A CO2017005500A2 (es) | 2014-12-18 | 2017-05-31 | Método para la producción de un sistema de administración farmacéutica |
Country Status (18)
Country | Link |
---|---|
US (1) | US20190022012A1 (es) |
EP (2) | EP3034070A1 (es) |
JP (1) | JP2017538733A (es) |
KR (1) | KR20170098894A (es) |
CN (1) | CN107106498A (es) |
AR (1) | AR103077A1 (es) |
AU (1) | AU2015367524B2 (es) |
BR (1) | BR112017012665A2 (es) |
CA (1) | CA2969763A1 (es) |
CO (1) | CO2017005500A2 (es) |
CR (1) | CR20170236A (es) |
MX (1) | MX2017007880A (es) |
PH (1) | PH12017501035A1 (es) |
RU (1) | RU2693491C2 (es) |
SG (1) | SG11201704513VA (es) |
TW (1) | TW201627009A (es) |
UY (1) | UY36444A (es) |
WO (1) | WO2016096997A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3069713A1 (en) | 2015-03-20 | 2016-09-21 | Omya International AG | Dispersible dosage form |
EP3260115A1 (en) | 2016-06-21 | 2017-12-27 | Omya International AG | Method for the production of a dosage form |
EP3260114A1 (en) | 2016-06-21 | 2017-12-27 | Omya International AG | Method for the production of a dosage form |
EP3269361A1 (en) | 2016-07-14 | 2018-01-17 | Omya International AG | Dosage form |
EP3275537A1 (en) * | 2016-07-25 | 2018-01-31 | Omya International AG | Surface-modified calcium carbonate as carrier for transition metal-based catalysts |
EP3520798A1 (en) * | 2018-01-31 | 2019-08-07 | Omya International AG | Use of functionalized calcium carbonate as active ingredient |
BR112021025200A2 (pt) | 2019-06-17 | 2022-02-01 | Dsm Ip Assets Bv | Composição compreendendo metformina hcl, vitamina b12 e pelo menos um aditivo de fluxo |
US20210059932A1 (en) * | 2019-08-28 | 2021-03-04 | Vincent Langlois | Multi-layer edible strip containing active medicinal ingredients |
CN111419815B (zh) * | 2020-04-23 | 2022-03-11 | 永信药品工业(昆山)股份有限公司 | 依托考昔片及其优化方法 |
TW202200206A (zh) | 2020-04-28 | 2022-01-01 | 瑞士商歐米亞國際公司 | 包含表面反應碳酸鈣作為賦形劑之顆粒 |
EP3928859A1 (en) | 2020-06-23 | 2021-12-29 | Omya International AG | Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule |
CN113413388B (zh) * | 2021-06-30 | 2022-11-15 | 上海奥全生物医药科技有限公司 | 含有枸橼酸西地那非的药物组合物、制备方法及其应用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5512411B2 (es) | 1974-03-12 | 1980-04-02 | ||
US4451260A (en) | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
US4985459A (en) | 1984-02-08 | 1991-01-15 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same |
JPS6143108A (ja) | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
PL149493B1 (en) | 1985-04-12 | 1990-02-28 | Method of obtaining a tablet capable to buoy over surface of gastric juice | |
US4627977A (en) | 1985-09-13 | 1986-12-09 | Colgate-Palmolive Company | Anticalculus oral composition |
GB8809421D0 (en) | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
WO1995005809A1 (fr) | 1993-08-20 | 1995-03-02 | Nippon Shinyaku Co., Ltd. | Preparation restant dans l'estomac, forme moulee gonflee, et procede de preparation |
FR2787802B1 (fr) | 1998-12-24 | 2001-02-02 | Pluss Stauffer Ag | Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications |
US6582738B2 (en) | 1999-09-13 | 2003-06-24 | Deseret Laboratories, Inc. | Process for preparing chewing gum containing a nutritional supplement |
DE60036205T2 (de) * | 2000-07-27 | 2008-05-21 | Roquette Frères | Granulat bestehend aus Stärke und Laktose |
CA2420461C (en) * | 2000-09-06 | 2008-08-12 | Tanabe Seiyaku Co., Ltd. | Preparations for oral administration |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
US20030157213A1 (en) | 2002-02-19 | 2003-08-21 | Jeffrey Jenkins | Nutrient chewing gum |
FR2852600B1 (fr) | 2003-03-18 | 2005-06-10 | Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages | |
FR2871474B1 (fr) | 2004-06-11 | 2006-09-15 | Omya Development Ag | Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages |
FR2881957B1 (fr) * | 2005-02-16 | 2008-08-08 | Solvay | Comprimes comprenant une substance biologiquement active et un excipient |
DE602007009124D1 (de) | 2007-12-12 | 2010-10-21 | Omya Development Ag | Verfahren zur Herstellung von oberflächenreaktives Fällungskalziumkarbonat |
EP2168572A1 (en) * | 2008-09-30 | 2010-03-31 | Omya Development Ag | New controlled release active agent carrier |
DK2264108T3 (da) | 2009-06-15 | 2012-05-29 | Omya Development Ag | Fremgangsmåde til fremstilling af et calciumcarbonat, der har reageret på overfladen, under anvendelse af en svag syre |
ATE542862T1 (de) | 2009-06-15 | 2012-02-15 | Omya Development Ag | Verfahren zur herstellung von oberflächenreaktivem kalziumkarbonat und verwendung |
SI2679638T1 (sl) | 2012-06-28 | 2015-11-30 | Omya International Ag | Vodna mineralna in/ali polnilna in/ali pigmentna suspenzija z visoko vrednostjo trdnih delcev v kislinskem ph okolju |
EP2719373B1 (en) * | 2012-10-12 | 2017-04-19 | Omya International AG | Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture |
HUE025008T2 (en) | 2012-10-12 | 2016-04-28 | Omya Int Ag | Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate |
EP2810656B1 (en) * | 2013-06-06 | 2017-08-02 | Zentiva, a.s. | Agomelatine formulations comprising agomelatine in the form of co-crystals |
RU2646113C1 (ru) * | 2016-09-06 | 2018-03-01 | Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) | Способ получения системы доставки фрагментов нуклеиновых кислот в клетки млекопитающих |
-
2014
- 2014-12-18 EP EP14199037.4A patent/EP3034070A1/en not_active Withdrawn
-
2015
- 2015-12-11 TW TW104141693A patent/TW201627009A/zh unknown
- 2015-12-16 WO PCT/EP2015/080016 patent/WO2016096997A1/en active Application Filing
- 2015-12-16 KR KR1020177020103A patent/KR20170098894A/ko not_active IP Right Cessation
- 2015-12-16 BR BR112017012665A patent/BR112017012665A2/pt not_active IP Right Cessation
- 2015-12-16 US US15/534,145 patent/US20190022012A1/en not_active Abandoned
- 2015-12-16 UY UY0001036444A patent/UY36444A/es not_active Application Discontinuation
- 2015-12-16 MX MX2017007880A patent/MX2017007880A/es unknown
- 2015-12-16 AU AU2015367524A patent/AU2015367524B2/en not_active Ceased
- 2015-12-16 SG SG11201704513VA patent/SG11201704513VA/en unknown
- 2015-12-16 EP EP15813352.0A patent/EP3233062A1/en not_active Withdrawn
- 2015-12-16 RU RU2017125320A patent/RU2693491C2/ru not_active IP Right Cessation
- 2015-12-16 CA CA2969763A patent/CA2969763A1/en not_active Abandoned
- 2015-12-16 CN CN201580069007.1A patent/CN107106498A/zh active Pending
- 2015-12-16 JP JP2017532816A patent/JP2017538733A/ja active Pending
- 2015-12-16 CR CR20170236A patent/CR20170236A/es unknown
- 2015-12-17 AR ARP150104151A patent/AR103077A1/es unknown
-
2017
- 2017-05-31 CO CONC2017/0005500A patent/CO2017005500A2/es unknown
- 2017-06-05 PH PH12017501035A patent/PH12017501035A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CR20170236A (es) | 2017-09-26 |
RU2693491C2 (ru) | 2019-07-03 |
RU2017125320A (ru) | 2019-01-18 |
AR103077A1 (es) | 2017-04-12 |
TW201627009A (zh) | 2016-08-01 |
AU2015367524B2 (en) | 2018-03-15 |
CA2969763A1 (en) | 2016-06-23 |
MX2017007880A (es) | 2017-09-05 |
UY36444A (es) | 2016-04-29 |
WO2016096997A1 (en) | 2016-06-23 |
US20190022012A1 (en) | 2019-01-24 |
BR112017012665A2 (pt) | 2017-12-26 |
AU2015367524A1 (en) | 2017-07-20 |
SG11201704513VA (en) | 2017-07-28 |
JP2017538733A (ja) | 2017-12-28 |
KR20170098894A (ko) | 2017-08-30 |
EP3034070A1 (en) | 2016-06-22 |
CN107106498A (zh) | 2017-08-29 |
EP3233062A1 (en) | 2017-10-25 |
RU2017125320A3 (es) | 2019-01-18 |
PH12017501035A1 (en) | 2018-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017005500A2 (es) | Método para la producción de un sistema de administración farmacéutica | |
PH12018500894A1 (en) | Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab | |
BR112018012145A2 (pt) | partículas de entrega de pró-sabor | |
CR20160450A (es) | Anticuerpos multiespecificos | |
CL2015002891A1 (es) | Deaza-purinonas macrocíclicas para el tratamiento de infecciones virales. | |
ES2897914T8 (es) | Compuestos que contienen nitrógeno, adecuados para el uso en la producción de poliuretanos | |
CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
BR112016018654A2 (pt) | Composições de silicato estabilizadas e seu uso como composições antiperspirantes | |
GT201700058A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
BR112015030268A2 (pt) | composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição | |
CL2016001210A1 (es) | Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis. | |
MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
DOP2017000058A (es) | Derivados de tetrahidroquinolina como inhibidores del bromodominio | |
UY36217A (es) | Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso. | |
AR100365A1 (es) | Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla | |
IN2014CH00840A (es) | ||
UY36064A (es) | Derivados quirales de ácido ciclopentancarboxílico 2,5-disustituidos y su uso | |
BR112016028083A2 (pt) | Composição oral farmacêutica de isotretinoina e seu processo de preparação | |
EA201691924A1 (ru) | Фармацевтические композиции | |
CL2015002069A1 (es) | Métodos para el uso de compuestos de fenoxipropilamina para tratar la depresión. | |
DK3258920T3 (da) | Fast farmaceutisk doseringsform, der er egnet til anvendelse som drikkevandsmedikament | |
EA201790526A1 (ru) | Фармацевтические комбинации ситаглиптина | |
ECSP17008187A (es) | Formas de dosificación farmacéutica |